Reasons to invest

Reason No. 4: We have an attractive portfolio of products, biotechnology solutions and processes

  • We possess extensive and well-founded knowledge concerning enzymes, microorganisms, cell-based test systems, and bioactive natural compounds. An interdisciplinary approach enables us to conceive and develop completely new products and services for our customers.
  • We do not limit ourselves to individual technologies and methods, but instead leverage our broad technology portfolio.
  • Bioinformatics forms a central element of our R&D expertise for faster and better solutions. In addition to our employees’ experience, we rely here on state-of-the-art technologies in the machine learning and artificial intelligence areas.
  • The targeted modification and programming of cells is one of BRAIN Biotech’s core competencies. In this context, we deploy all commercially available technologies as well as our proprietary nucleases G-dase M® and G-dase E® for genome editing.
  • We are an expert solution provider for industry – from research and the scaling up of industrial biological processes to the production of enzymes and proteins.
  • More than thirty years of experience, around 600 available products for our B2B customers, and over 200 successfully completed industrial cooperation projects are strong testimony to our success.

Share this page